Treatment of thromBocytopenia With EltRombopag or Intravenous Immune Globulin (IVIG) Before and DurING Invasive Procedures in Patients With Immune ThrombocytoPenia- BRIDGING ITP Study
Phase of Trial: Phase III
Latest Information Update: 06 Sep 2018
At a glance
- Drugs Eltrombopag (Primary) ; Immune globulin
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- Acronyms BRIDGING ITP
- 14 Jun 2018 Planned End Date changed from 1 Aug 2018 to 1 Jan 2019.
- 14 Jun 2018 Planned primary completion date changed from 1 Aug 2018 to 1 Jan 2019.
- 16 Mar 2016 Planned End Date changed from 1 Aug 2016 to 1 Aug 2018 as per ClinicalTrials.gov record.